Presentation
17 March 2023 Microbiome change as a mechanism of photobiomodulation
Brian Bicknell, Ann Liebert
Author Affiliations +
Abstract
The gut microbiome has been increasingly recognised as crucial to health and has been shown to be disrupted in such diverse diseases and conditions as cardiovascular disease, renal disease, liver disease, lung infections, osteoarthritis. In addition, the microbiome-gut-brain axis has been shown to be a vital link in the neurological and neurodegenerative disorders of Alzheimer’s disease, Parkinson’s disease, autism spectrum disorder and depression. We have previously demonstrated the effect that PBM can have on the microbiome of healthy mice. In this presentation, results from a number of case studies from human trials will be presented, suggesting the potential of PBM to influence the microbiome in a positive manner. These changes correspond to improvements in a number of measures of human health in cancer treatment, Parkinson’s disease and metabolic syndrome. The interaction between light and the microbiome will be explored.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Brian Bicknell and Ann Liebert "Microbiome change as a mechanism of photobiomodulation", Proc. SPIE PC12362, Mechanisms of Photobiomodulation Therapy XVII, PC1236206 (17 March 2023); https://doi.org/10.1117/12.2653095
Advertisement
Advertisement
KEYWORDS
Alzheimer's disease

Cancer

Diseases and disorders

Liver

Lung

Oncology

Back to Top